Drug Repurposing in COVID-19
July 15th, 2022
The aim of this review is to describe regulatory and pharmacological aspects of drug repurposing and to identify drugs proposed for repurposing in COVID-19 based on the evidence to support their use in the treatment of this disease.The challenges of the correct interpretation of existing pre-clinical/clinical evidence as well as the generation of new evidence concerning drug repurposing in COVID-19 will also be discussed.
Struggling to find relevant content? Order a custom essay on
Drug Repurposing in COVID-19
Let our experts save you the hassle